Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Discontinuing colchicine in symptomatic carriers for MEFV (Mediterranean FeVer) variants.

Clinical rheumatology - 1 Feb 2017

Sönmez Hafize Emine, Batu Ezgi Deniz, Bilginer Yelda, Özen Seza

Abstract excerpt

Familial Mediterranean fever (FMF) is inherited autosomal recessively; however, heterozygotes may express FMF phenotype. We aimed to define the characteristics of FMF patients heterozygous for MEFV (MEditerranean FeVer) mutations in whom colchicine was stopped after a period of treatment, with close follow-up. We reviewed the charts of 182 children who were heterozygous for MEFV variants. We excluded the patients...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Colchicine
Share to Familial Mediterranean Fever
Share to Follow-Up Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Heterozygote

Share to Homozygote

Share to Inflammation

Share to Recurrence

Share to Tubulin Modulators

Source

Identifiers

PMID: 27679472
DOI: 10.1007/s10067-016-3421-8

Genes

MEFV

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Discontinuing colchicine in symptomatic carriers for MEFV (Mediterranean FeVer) variants.PMID 27679472Read ↗

Colchicine discontinuation in familial Mediterranean fever: short-term outcomes by pre-discontinuation attack frequency.Semantic proximity Read ↗

Discontinuing Colchicine in Pediatric Familial Mediterranean Fever: Real-Life Experience from a Long-Term Follow-Up Cohort.Semantic proximity Read ↗

Re-evaluation of MEFV carriers previously diagnosed with FMF: a colchicine discontinuation study.Semantic proximity Read ↗

Is the decision maker a key determinant of colchicine withdrawal success in paediatric heterozygous familial Mediterranean fever patients?Semantic proximity Read ↗

Familial Mediterranean fever in heterozygotes: are we able to accurately diagnose the disease in very young children?Semantic proximity Read ↗

Clinical, genetic, and therapeutic differences in pediatric versus adult colchicine-resistant FMF patients.Semantic proximity Read ↗

The expanded clinical profile and the efficacy of colchicine therapy in Egyptian children suffering from familial Mediterranean fever: a descriptive study.Semantic proximity Read ↗

Prophylactic colchicine for familial Mediterranean fever: response rates revisited.Semantic proximity Read ↗

A survey of resistance to colchicine treatment for French patients with familial Mediterranean fever.Semantic proximity Read ↗

FMF is not always "fever": from clinical presentation to "treat to target".Semantic proximity Read ↗

Is colchicine more effective to prevent periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis episodes in Mediterranean fever gene variants?Semantic proximity Read ↗

Early predictors of colchicine resistance in familial Mediterranean fever.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.